Published in J Neurol on April 01, 2000
Characteristics of Parkinson s Disease Associated With the LRRK-2 Gene Mutation | NCT00467090
Pathological α-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science (2012) 6.66
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun (2011) 3.23
The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci (2013) 2.78
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study. Eur J Nucl Med Mol Imaging (2012) 2.01
Cell therapy in Parkinson's disease. NeuroRx (2004) 1.93
Selective molecular alterations in the autophagy pathway in patients with Lewy body disease and in models of alpha-synucleinopathy. PLoS One (2010) 1.92
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neuropathol (2013) 1.75
Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS One (2010) 1.72
Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. J Neurochem (2009) 1.52
Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer (2011) 1.45
Redox imbalance in Parkinson's disease. Biochim Biophys Acta (2008) 1.39
Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA. J Neural Transm (Vienna) (2008) 1.25
Clinically relevant effects of convection-enhanced delivery of AAV2-GDNF on the dopaminergic nigrostriatal pathway in aged rhesus monkeys. Hum Gene Ther (2009) 1.21
The prion hypothesis in Parkinson's disease: Braak to the future. Acta Neuropathol Commun (2013) 1.11
Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol (2005) 1.07
Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci (2008) 1.06
Very low levels of education and cognitive reserve: a clinicopathologic study. Neurology (2013) 1.06
Testing basal ganglia motor functions through reversible inactivations in the posterior internal globus pallidus. J Neurophysiol (2007) 1.05
Distribution of nanoparticles throughout the cerebral cortex of rodents and non-human primates: Implications for gene and drug therapy. Front Neuroanat (2014) 1.01
Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBD. Mol Ther (2012) 1.00
Basal ganglia activity patterns in parkinsonism and computational modeling of their downstream effects. Eur J Neurosci (2012) 0.97
Automated, high accuracy classification of Parkinsonian disorders: a pattern recognition approach. PLoS One (2013) 0.95
Autophagy in dementias. Brain Pathol (2012) 0.95
Effects of subthalamic nucleus stimulation and levodopa on the autonomic nervous system in Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 0.95
Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state. Front Neuroanat (2015) 0.93
Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity. PLoS One (2010) 0.93
Unique responses to mitochondrial complex I inhibition in tuberoinfundibular dopamine neurons may impart resistance to toxic insult. Neuroscience (2007) 0.92
Startle reflex hyporeactivity in Parkinson's disease: an emotion-specific or arousal-modulated deficit? Neuropsychologia (2009) 0.92
Thalamic projection fiber integrity in de novo Parkinson disease. AJNR Am J Neuroradiol (2012) 0.91
Many Faces of Parkinson's Disease: Non-Motor Symptoms of Parkinson's Disease. J Mov Disord (2015) 0.90
The mesopontine rostromedial tegmental nucleus: an integrative modulator of the reward system. Basal Ganglia (2011) 0.90
Weight changes in subthalamic nucleus vs globus pallidus internus deep brain stimulation: results from the COMPARE Parkinson disease deep brain stimulation cohort. Neurosurgery (2011) 0.88
Cyclooxygenase and neuroinflammation in Parkinson's disease neurodegeneration. Curr Neuropharmacol (2010) 0.88
Diffusion tensor imaging of Parkinson's disease, multiple system atrophy and progressive supranuclear palsy: a tract-based spatial statistics study. PLoS One (2014) 0.88
Phosphorylated α-synuclein-immunoreactive retinal neuronal elements in Parkinson's disease subjects. Neurosci Lett (2014) 0.86
Parkinson's disease: a complex interplay of mitochondrial DNA alterations and oxidative stress. Int J Mol Sci (2013) 0.86
The contribution of alpha synuclein to neuronal survival and function - Implications for Parkinson's disease. J Neurochem (2016) 0.85
Sympathetic noradrenergic before striatal dopaminergic denervation: relevance to Braak staging of synucleinopathy. Clin Auton Res (2011) 0.85
Concordant signaling pathways produced by pesticide exposure in mice correspond to pathways identified in human Parkinson's disease. PLoS One (2012) 0.85
Nonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeys. PLoS One (2012) 0.85
Gene expression in the Parkinson's disease brain. Brain Res Bull (2011) 0.85
Recovery of hypothalamic tuberoinfundibular dopamine neurons from acute toxicant exposure is dependent upon protein synthesis and associated with an increase in parkin and ubiquitin carboxy-terminal hydrolase-L1 expression. Neurotoxicology (2012) 0.84
Targeting impulsivity in Parkinson's disease using atomoxetine. Brain (2014) 0.84
High-level language production in Parkinson's disease: a review. Parkinsons Dis (2011) 0.84
Parkin mutations reduce the complexity of neuronal processes in iPSC-derived human neurons. Stem Cells (2015) 0.84
Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies. J Neurochem (2011) 0.83
Dementia with Lewy bodies. Neurol Clin (2007) 0.83
Mechanisms of body weight fluctuations in Parkinson's disease. Front Neurol (2014) 0.82
Sustained resistance to acute MPTP toxicity by hypothalamic dopamine neurons following chronic neurotoxicant exposure is associated with sustained up-regulation of parkin protein. Neurotoxicology (2013) 0.82
shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson's disease model. J Clin Invest (2015) 0.82
Parkinson's disease. Subcell Biochem (2012) 0.82
Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl. J Neural Transm (Vienna) (2005) 0.81
Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson's disease. Dysphagia (2009) 0.81
Imaging changes associated with cognitive abnormalities in Parkinson's disease. Brain Struct Funct (2014) 0.81
Dopamine effects on identified rat vagal motoneurons. Am J Physiol Gastrointest Liver Physiol (2006) 0.81
Mild cognitive impairment in Parkinson's disease. J Neural Transm (Vienna) (2013) 0.81
Vanadium exposure induces olfactory dysfunction in an animal model of metal neurotoxicity. Neurotoxicology (2013) 0.81
The bowel and beyond: the enteric nervous system in neurological disorders. Nat Rev Gastroenterol Hepatol (2016) 0.80
Diffusion tensor imaging and correlations to Parkinson rating scales. J Neurol (2013) 0.80
Pathomechanisms and compensatory efforts related to Parkinsonian speech. Neuroimage Clin (2013) 0.80
Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons. J Neurosci (2013) 0.80
Differential sialylation of serpin A1 in the early diagnosis of Parkinson's disease dementia. PLoS One (2012) 0.79
Abnormal pulmonary function and respiratory muscle strength findings in Chinese patients with Parkinson's disease and multiple system atrophy--comparison with normal elderly. PLoS One (2014) 0.79
Reduced hypocretin (orexin) levels in dementia with Lewy bodies. Neuroreport (2010) 0.79
Brain region-specific gene expression profiles in freshly isolated rat microglia. Front Cell Neurosci (2015) 0.79
Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease. J Neurol (2016) 0.78
Alpha-Synuclein Oligomers-Neurotoxic Molecules in Parkinson's Disease and Other Lewy Body Disorders. Front Neurosci (2016) 0.78
Does a prion-like mechanism play a major role in the apparent spread of α-synuclein pathology? Alzheimers Res Ther (2012) 0.78
α-Synuclein interferes with the ESCRT-III complex contributing to the pathogenesis of Lewy body disease. Hum Mol Genet (2016) 0.77
Changes of brain gray matter structure in Parkinson's disease patients with dementia. Neural Regen Res (2013) 0.77
Mitochondrial abnormality associates with type-specific neuronal loss and cell morphology changes in the pedunculopontine nucleus in Parkinson disease. Am J Pathol (2013) 0.77
Serotonergic modulation of Neural activities in the entorhinal cortex. Int J Physiol Pathophysiol Pharmacol (2012) 0.77
Generalized motor inhibitory deficit in Parkinson's disease patients who freeze. J Neural Transm (Vienna) (2015) 0.77
Elevated α-synuclein caused by SNCA gene triplication impairs neuronal differentiation and maturation in Parkinson's patient-derived induced pluripotent stem cells. Cell Death Dis (2015) 0.77
Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere. Brain Behav (2016) 0.76
Neuroactive compounds obtained from arthropod venoms as new therapeutic platforms for the treatment of neurological disorders. J Venom Anim Toxins Incl Trop Dis (2015) 0.76
Perception of speech by individuals with Parkinson's disease: a review. Parkinsons Dis (2011) 0.76
The contribution of trail making to the prediction of performance-based instrumental activities of daily living in Parkinson's disease without dementia. J Clin Exp Neuropsychol (2013) 0.76
Alpha-synucleinopathy and neuropsychological symptoms in a population-based cohort of the elderly. Alzheimers Res Ther (2015) 0.76
Reduced CA2-CA3 Hippocampal Subfield Volume Is Related to Depression and Normalized by l-DOPA in Newly Diagnosed Parkinson's Disease. Front Neurol (2017) 0.75
Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis. P T (2015) 0.75
Gastric dysregulation induced by microinjection of 6-OHDA in the substantia nigra pars compacta of rats is determined by alterations in the brain-gut axis. Am J Physiol Gastrointest Liver Physiol (2014) 0.75
Discriminating among degenerative parkinsonisms using advanced (123)I-ioflupane SPECT analyses. Neuroimage Clin (2016) 0.75
Parkinsonian Balance Deficits Quantified Using a Game Industry Board and a Specific Battery of Four Paradigms. Front Hum Neurosci (2016) 0.75
The Alterations of Cortical Volume, Thickness, Surface, and Density in the Intermediate Sporadic Parkinson's Disease from the Han Population of Mainland China. Front Aging Neurosci (2016) 0.75
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy. Acta Neuropathol Commun (2017) 0.75
PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease. Front Mol Neurosci (2017) 0.75
Abnormalities in Structural Covariance of Cortical Gyrification in Parkinson's Disease. Front Neuroanat (2017) 0.75
More than a Rumor Spreads in Parkinson's Disease. Front Hum Neurosci (2016) 0.75
Parkinson's Disease and Cognitive Impairment. Parkinsons Dis (2016) 0.75
Reduced task-related functional connectivity during a set-shifting task in unmedicated early-stage Parkinson's disease patients. BMC Neurosci (2016) 0.75
Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease. Aging Dis (2016) 0.75
Predictors of HVOT performance in Parkinson's disease. Appl Neuropsychol (2011) 0.75
Comparison of the structure, function and autophagic maintenance of mitochondria in nigrostriatal and tuberoinfundibular dopamine neurons. Brain Res (2015) 0.75
N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data. PLoS One (2016) 0.75
FTY720/Fingolimod Reduces Synucleinopathy and Improves Gut Motility in A53T Mice: CONTRIBUTIONS OF PRO-BRAIN-DERIVED NEUROTROPHIC FACTOR (PRO-BDNF) AND MATURE BDNF. J Biol Chem (2016) 0.75
Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease. Mol Ther Methods Clin Dev (2016) 0.75
Testosterone level and the effect of levodopa and agonists in early Parkinson disease: results from the INSPECT cohort. J Clin Mov Disord (2014) 0.75
Analyzing the effectiveness of vocal features in early telediagnosis of Parkinson's disease. PLoS One (2017) 0.75
Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex. Mov Disord (2017) 0.75
Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (1991) 49.03
Frequency of stages of Alzheimer-related lesions in different age categories. Neurobiol Aging (1997) 7.54
Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging (1995) 6.86
Staging of Alzheimer-related cortical destruction. Eur Neurol (1993) 3.58
Occurrence of neuropil threads in the senile human brain and in Alzheimer's disease: a third location of paired helical filaments outside of neurofibrillary tangles and neuritic plaques. Neurosci Lett (1986) 3.36
Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol (1991) 3.35
Evolution of the neuropathology of Alzheimer's disease. Acta Neurol Scand Suppl (1996) 3.02
Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl (1998) 2.83
Alzheimer's disease: striatal amyloid deposits and neurofibrillary changes. J Neuropathol Exp Neurol (1990) 2.78
Diagnostic criteria for neuropathologic assessment of Alzheimer's disease. Neurobiol Aging (1997) 2.59
On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's disease. Acta Neuropathol (1985) 2.58
Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol (1989) 2.56
Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol (1988) 2.55
Alzheimer's disease affects limbic nuclei of the thalamus. Acta Neuropathol (1991) 2.41
Neuropil threads occur in dendrites of tangle-bearing nerve cells. Neuropathol Appl Neurobiol (1988) 2.11
Alzheimer's disease: areal and laminar pathology in the occipital isocortex. Acta Neuropathol (1989) 2.09
Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol (1999) 2.08
Alzheimer's disease: amyloid plaques in the cerebellum. J Neurol Sci (1989) 2.08
Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathol (1990) 2.05
The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes. Brain Res (1989) 1.93
Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques. Neurosci Lett (1989) 1.91
Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol (1996) 1.83
High frequency of apolipoprotein E epsilon4 allele in young individuals with very mild Alzheimer's disease-related neurofibrillary changes. Exp Neurol (1998) 1.82
Distribution, levels, and activity of glycogen synthase kinase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol (1997) 1.63
Evolution of Alzheimer's disease related cortical lesions. J Neural Transm Suppl (1998) 1.57
Functional anatomy of human hippocampal formation and related structures. J Child Neurol (1996) 1.53
Staging of Alzheimer-related cortical destruction. Int Psychogeriatr (1997) 1.44
Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder. Neurobiol Aging (1994) 1.42
Sequence of Abeta-protein deposition in the human medial temporal lobe. J Neuropathol Exp Neurol (2000) 1.37
The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases. Neurosci Res (1992) 1.30
Assessment of the pathological stages of Alzheimer's disease in thin paraffin sections: a comparative study. Dement Geriatr Cogn Disord (1998) 1.30
Vulnerability of select neuronal types to Alzheimer's disease. Ann N Y Acad Sci (2000) 1.29
Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm (Vienna) (1996) 1.20
Extensive axonal Lewy neurites in Parkinson's disease: a novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett (1999) 1.15
Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol (2000) 1.14
The progression of Alzheimer's disease from limbic regions to the neocortex: clinical, radiological and pathological relationships. Dement Geriatr Cogn Disord (1999) 1.14
Gender and age modify the association between APOE and AD-related neuropathology. Neurology (2001) 1.12
Nigral and extranigral pathology in Parkinson's disease. J Neural Transm Suppl (1995) 1.09
Argyrophilic grains: characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett (1987) 1.08
Argyrophilic grain disease: frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm (Vienna) (1998) 1.08
Abnormally phosphorylated tau protein related to the formation of neurofibrillary tangles and neuropil threads in the cerebral cortex of sheep and goat. Neurosci Lett (1994) 1.06
Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by 'stages': a prospective study. Dement Geriatr Cogn Disord (1999) 1.04
Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol (2000) 1.02
The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei. Neuropathol Appl Neurobiol (2000) 1.01
Amygdala pathology in Parkinson's disease. Acta Neuropathol (1994) 0.99
Amyloid beta-protein (Abeta)-containing astrocytes are located preferentially near N-terminal-truncated Abeta deposits in the human entorhinal cortex. Acta Neuropathol (2000) 0.97
Staging of Alzheimer-type pathology: an interrater-intrarater study. Dement Geriatr Cogn Disord (1997) 0.96
Cognitive impairment in Parkinson's disease: amyloid plaques, neurofibrillary tangles, and neuropil threads in the cerebral cortex. J Neural Transm Park Dis Dement Sect (1990) 0.96
Allocortical neurofibrillary changes in progressive supranuclear palsy. Acta Neuropathol (1992) 0.95
Neuronal types in the claustrum of man. Anat Embryol (Berl) (1982) 0.91
Neuropathological hallmarks of Alzheimer's and Parkinson's diseases. Prog Brain Res (1998) 0.91
Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease. Neurosci Lett (1996) 0.91
The autonomic higher order processing nuclei of the lower brain stem are among the early targets of the Alzheimer's disease-related cytoskeletal pathology. Acta Neuropathol (2001) 0.91
Alzheimer lesions in the entorhinal region and isocortex in Parkinson's and Alzheimer's diseases. Ann N Y Acad Sci (1991) 0.90
Pathological changes in the parahippocampal region in select non-Alzheimer's dementias. Ann N Y Acad Sci (2000) 0.90
Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Abeta. J Neuropathol Exp Neurol (1999) 0.89
A silver impregnation method for labeling both Alzheimer paired helical filaments and their polypeptides separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Neurobiol Aging (1992) 0.88
The pyramidal cells of Betz within the cingulate and precentral gigantopyramidal field in the human brain. A Golgi and pigmentarchitectonic study. Cell Tissue Res (1976) 0.86
Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique. Acta Neuropathol (1999) 0.86
Allocortical involvement in Huntington's disease. Neuropathol Appl Neurobiol (1992) 0.86
Nuclear configuration and neuronal types of the nucleus niger in the brain of the human adult. Hum Neurobiol (1986) 0.85
Golgi preparations as a tool in neuropathology with particular reference to investigations of the human telencephalic cortex. Prog Neurobiol (1985) 0.85
On layer III pyramidal cells in the parastriate borderzone of man. J Hirnforsch (1985) 0.85
Ratio of pyramidal cells versus non-pyramidal cells in the human frontal isocortex and changes in ratio with ageing and Alzheimer's disease. Prog Brain Res (1986) 0.85
Neuronal types in the striatum of man. Cell Tissue Res (1982) 0.84
On the fine structure of the small, heavily pigmented non-pyramidal cells in lamina II and upper lamina III of the human isocortex. Cell Tissue Res (1976) 0.84
Age-related progression of tau pathology in brains of baboons. Neurobiol Aging (2001) 0.84
On three types of large nerve cells in the granular layer of the human cerebellar cortex. Anat Embryol (Berl) (1983) 0.84
Entorhinal-hippocampal interaction in mnestic disorders. Hippocampus (1993) 0.83
The hypothalamus of the human adult: chiasmatic region. Anat Embryol (Berl) (1987) 0.83
Expression of stress proteins alpha B-crystallin, ubiquitin, and hsp27 in pallido-nigral spheroids of aged rhesus monkeys. Neurobiol Aging (2001) 0.83
Morphological studies of local circuit neurons in the cerebellar dentate nucleus of man. Hum Neurobiol (1983) 0.82
On the fine structure of the external glial layer in the isocortex of man. Cell Tissue Res (1975) 0.82
[Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems]. Nervenarzt (2000) 0.81
Parvalbumin-immunoreactive structures of the adult human entorhinal and transentorhinal region. Hippocampus (1993) 0.81
New aspects of pathology in Parkinson's disease with concomitant incipient Alzheimer's disease. J Neural Transm Suppl (1996) 0.81
Sex-dependent cytoskeletal changes of the human hypothalamus develop independently of Alzheimer's disease. Exp Neurol (1999) 0.81
A sex difference in neurodegeneration of the human hypothalamus. Neurosci Lett (1996) 0.81
Filamentous tau pathology in nerve cells, astrocytes, and oligodendrocytes of aged baboons. J Neuropathol Exp Neurol (2000) 0.81
Parvalbumin-immunoreactive neurons in the human claustrum. Brain Struct Funct (2013) 0.81
Isocortical pathology in type C Niemann-Pick disease. A combined Golgi-pigmentoarchitectonic study. J Neuropathol Exp Neurol (1983) 0.81
The fine structure of myelinated nerve cell bodies in the bulbus olfactorius of man. Cell Tissue Res (1977) 0.80
Age-related alterations of the proximal axon segment in lamina IIIab-pyramidal cells of the human isocortex. A Golgi and fine structural study. J Hirnforsch (1980) 0.80
A method of firmly attaching 4-10micron thick araldite serial sections to glass slides for light microscopic staining procedures. Stain Technol (1977) 0.80
[Do the island neurons of regio entorhinalis belong to the class of pyramid or star-shaped cells?]. Z Mikrosk Anat Forsch (1976) 0.80
[Morphological changes in the human cerebral cortex in dementia]. J Hirnforsch (1991) 0.79
Argyrophilic grain disease is associated with apolipoprotein E epsilon 2 allele. Acta Neuropathol (1998) 0.79
Glutamic acid decarboxylase immunoreactivity in sector CA1 of the human Ammon's horn. Anat Embryol (Berl) (1986) 0.79
Neurofibrillary pathology in the human paraventricular and supraoptic nuclei. Acta Neuropathol (1997) 0.79
Projection neurons of basolateral amygdaloid nuclei develop meganeurites in juvenile and adult human neuronal ceroid lipofuscinosis. Clin Neuropathol (1987) 0.79
Calbindin-D-28k-like immunoreactive structures in the olfactory bulb and anterior olfactory nucleus of the human adult: distribution and cell typology--partial complementarity with parvalbumin. Neuroscience (1991) 0.79
[Staining the Nissl bodies in 4--10 microns thick Araldite sections with an area of about 2x2 cm (author's transl)]. Microsc Acta (1976) 0.79
On the structure of the human striate area. Lamina IVcbeta. Cell Tissue Res (1978) 0.78
Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease. Brain Res (1998) 0.78
Anatomy of the human hypothalamus (chiasmatic and tuberal region). Prog Brain Res (1992) 0.78
Pigment-filled appendages of the small spiny neurons: a severe pathological change of the striatum in neuronal ceroid lipofuscinosis. Neuropathol Appl Neurobiol (1980) 0.78
Tau pathology in neurons and glial cells of aged baboons. Adv Exp Med Biol (2001) 0.78
Neuropeptide Y-like immunoreactive neurons in the human olfactory bulb. Brain Res (1988) 0.77
Vasopressinergic neurons in the magnocellular nuclei of the human basal forebrain. Brain Res (1990) 0.77